AAAAAA
Results:
1-15
|
Results: 15
Authors:
JOHNSTON PS
FEIG PU
CONIFF RF
KROL A
DAVIDSON JA
HAFFNER SM
Citation: Ps. Johnston et al., LONG-TERM TITRATED-DOSE ALPHA-GLUCOSIDASE INHIBITION IN NON-INSULIN-REQUIRING HISPANIC NIDDM PATIENTS, Diabetes care, 21(3), 1998, pp. 409-415
Authors:
JOHNSTON PS
FEIG PU
CONIFF RF
KROL A
KELLEY DE
MOORADIAN AD
Citation: Ps. Johnston et al., CHRONIC TREATMENT OF AFRICAN-AMERICAN TYPE-2 DIABETIC-PATIENTS WITH ALPHA-GLUCOSIDASE INHIBITION, Diabetes care, 21(3), 1998, pp. 416-422
Authors:
JOHNSTON PS
LEBOVITZ HE
CONIFF RF
SIMONSON DC
RASKIN P
MUNERA CL
Citation: Ps. Johnston et al., ADVANTAGES OF ALPHA-GLUCOSIDASE INHIBITION AS MONOTHERAPY IN ELDERLY TYPE-2 DIABETIC-PATIENTS, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1515-1522
Authors:
CONIFF RF
Citation: Rf. Coniff, THE BAYER-022 COMPASSIONATE-USE PEDIATRIC STUDY, The Annals of thoracic surgery, 65(6), 1998, pp. 31-33
Authors:
YOST P",DIETRICH,"MUNRO H
LEVY JH
CONIFF RF
Citation: H. Yost P",dietrich,"munro et al., INCIDENCE OF HYPERSENSITIVITY REACTIONS - DISCUSSION, The Annals of thoracic surgery, 65(6), 1998, pp. 64-64
Authors:
HOLLANDER P
PISUNYER X
CONIFF RF
Citation: P. Hollander et al., ACARBOSE IN THE TREATMENT OF TYPE-I DIABETES, Diabetes care, 20(3), 1997, pp. 248-253
Authors:
CONIFF RF
JOHNSTON PS
KROL A
Citation: Rf. Coniff et al., LONG-TERM EFFECTS OF THE ALPHA-GLUCOSIDASE INHIBITOR MIGLITOL (BAY-M-1099) IN NIDDM PATIENTS TREATED WITH MAXIMAL-DOSE SULFONYLUREA (SFU), Diabetes, 45, 1996, pp. 815-815
Authors:
PASMANTIER R
JOHNSTON P
CONIFF RF
LEBOVITZ HE
Citation: R. Pasmantier et al., COMBINATION MIGLITOL AND NPH INSULIN-TREATMENT IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Diabetes, 45, 1996, pp. 1065-1065
Authors:
CONIFF RF
SHAPIRO JA
SEATON TB
HOOGWERF BJ
HUNT JA
Citation: Rf. Coniff et al., A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ACARBOSE FOR THE TREATMENT OF PATIENTS WITH INSULIN-REQUIRINGTYPE-II DIABETES, Diabetes care, 18(7), 1995, pp. 928-932
Authors:
CONIFF RF
SHAPIRO JA
ROBBINS D
KLEINFIELD R
SEATON TB
BEISSWENGER P
MCGILL JB
Citation: Rf. Coniff et al., REDUCTION OF GLYCOSYLATED HEMOGLOBIN AND POSTPRANDIAL HYPERGLYCEMIA BY ACARBOSE IN PATIENTS WITH NIDDM - A PLACEBO-CONTROLLED DOSE-COMPARISON STUDY, Diabetes care, 18(6), 1995, pp. 817-824
Authors:
CONIFF RF
SHAPIRO J
SEATON TB
BRAY GA
Citation: Rf. Coniff et al., MULTICENTER, PLACEBO-CONTROLLED TRIAL COMPARING ACARBOSE (BAY G-5421)WITH PLACEBO, TOLBUTAMIDE, AND TOLBUTAMIDE-PLUS-ACARBOSE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The American journal of medicine, 98(5), 1995, pp. 443-451
Authors:
JOHNSTON PS
SANTIAGO JV
CONIFF RF
PISUNYER FX
HOOGWERF BJ
KROL A
Citation: Ps. Johnston et al., EFFECTS OF THE CARBOHYDRASE INHIBITOR MIGLITOL IN SULFONYLUREA-TREATED NIDDM PATIENTS, Diabetes care, 17(1), 1994, pp. 20-29
Authors:
SEATON TB
CONIFF RF
Citation: Tb. Seaton et Rf. Coniff, ACARBOSE (BAY-G 5421) DOSE-RANGING STUDY IN DIET-TREATED NIDDM PATIENTS, Diabetes, 43, 1994, pp. 10000063-10000063
Authors:
CONIFF RF
SHAPIRO JA
SEATON TB
Citation: Rf. Coniff et al., LONG-TERM EFFICACY AND SAFETY OF ACARBOSE IN THE TREATMENT OF OBESE SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Archives of internal medicine, 154(21), 1994, pp. 2442-2448
Authors:
JOHNSTON PS
CONIFF RF
Citation: Ps. Johnston et Rf. Coniff, MIGLITOL (BAY M-1099) TREATMENT OF NIDDM PATIENTS TREATED WITH DIET AND MAXIMAL DAILY DOSES OF SULFONYLUREA (SFU), Diabetes, 42, 1993, pp. 79-79
Risultati:
1-15
|